NRC Health Long-Term Debt, Maturity, Remainder of Fiscal Year
NRC Health (NRC) had Long-Term Debt, Maturity, Remainder of Fiscal Year of $3.71 million as of 2018-12-31, per its 10-K filed 2019-03-08.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear · last filed 2019-03-08
- 2018-12-31: Long-Term Debt, Maturity, Remainder of Fiscal Year $3.71M.
- 2018-09-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $901.00K.
- 2018-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $1.79M.
| Period end | Long-Term Debt, Maturity, Remainder of Fiscal Year |
|---|---|
| 2018-12-31 | $3.71M 10-K · filed 2019-03-08 |
| 2018-09-30 | $901.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $1.79M 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |